Park HJ - Search Results

1

PBT-6, a Novel PI3KC2γ Inhibitor in Rheumatoid Arthritis.

Kim J, Jung KH, Yoo J, Park JH, Yan HH, Fang Z, Lim JH, Kwon SR, Kim MK, Park HJ, Hong SS. Kim J, et al. Among authors: park jh, park hj. Biomol Ther (Seoul). 2020 Mar 1;28(2):172-183. doi: 10.4062/biomolther.2019.153. Biomol Ther (Seoul). 2020. PMID: 31739383 Free PMC article.

2

Role of Helix 8 in Dopamine Receptor Signaling.

Yang HS, Sun N, Zhao X, Kim HR, Park HJ, Kim KM, Chung KY. Yang HS, et al. Among authors: park hj. Biomol Ther (Seoul). 2019 Nov 1;27(6):514-521. doi: 10.4062/biomolther.2019.026. Biomol Ther (Seoul). 2019. PMID: 30971061 Free PMC article.

3

Lobatamunsolides A-C, Norlignans from the Roots of Pueraria lobata and their Nitric Oxide Inhibitory Activities in Macrophages.

Jo MS, Yu JS, Lee JC, Lee S, Cho YC, Park HJ, Kim KH. Jo MS, et al. Among authors: park hj. Biomolecules. 2019 Nov 20;9(12):755. doi: 10.3390/biom9120755. Biomolecules. 2019. PMID: 31757072 Free PMC article.

4

Structure-Activity Relationship Study and Biological Evaluation of 2-(Disubstituted phenyl)-indole-5-propanoic Acid Derivatives as GPR40 Full Agonists.

Zhao X, Yoon DO, Yoo J, Park HJ. Zhao X, et al. Among authors: park hj. J Med Chem. 2021 Apr 8;64(7):4130-4149. doi: 10.1021/acs.jmedchem.1c00031. Epub 2021 Mar 26. J Med Chem. 2021. PMID: 33769827

5

Cinnamamides, Novel Liver X Receptor Antagonists that Inhibit Ligand-Induced Lipogenesis and Fatty Liver.

Sim WC, Kim DG, Lee KJ, Choi YJ, Choi YJ, Shin KJ, Jun DW, Park SJ, Park HJ, Kim J, Oh WK, Lee BH. Sim WC, et al. Among authors: park sj, park hj. J Pharmacol Exp Ther. 2015 Dec;355(3):362-9. doi: 10.1124/jpet.115.226738. Epub 2015 Sep 18. J Pharmacol Exp Ther. 2015. PMID: 26384859

6

Compound 9a, a novel synthetic histone deacetylase inhibitor, protects against septic injury in mice by suppressing MAPK signalling.

Kim SJ, Baek KS, Park HJ, Jung YH, Lee SM. Kim SJ, et al. Among authors: park hj. Br J Pharmacol. 2016 Mar;173(6):1045-57. doi: 10.1111/bph.13414. Epub 2016 Feb 22. Br J Pharmacol. 2016. PMID: 26689981 Free PMC article.

7

Computer-Aided Discovery of Massonianoside B as a Novel Selective DOT1L Inhibitor.

Chen J, Park HJ. Chen J, et al. Among authors: park hj. ACS Chem Biol. 2019 May 17;14(5):873-881. doi: 10.1021/acschembio.8b00933. Epub 2019 Apr 16. ACS Chem Biol. 2019. PMID: 30951287

8

Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer.

Nam KH, Yi SA, Nam G, Noh JS, Park JW, Lee MG, Park JH, Oh H, Lee J, Lee KR, Park HJ, Lee J, Han JW. Nam KH, et al. Among authors: park jh, park jw, park hj. BMC Cancer. 2019 Aug 6;19(1):773. doi: 10.1186/s12885-019-5997-2. BMC Cancer. 2019. PMID: 31387554 Free PMC article.

9

A novel C-terminal heat shock protein 90 inhibitor that overcomes STAT3-Wnt-β-catenin signaling-mediated drug resistance and adverse effects.

Lee HJ, Min HY, Yong YS, Ann J, Nguyen CT, La MT, Hyun SY, Le HT, Kim H, Kwon H, Nam G, Park HJ, Lee J, Lee HY. Lee HJ, et al. Among authors: park hj. Theranostics. 2022 Jan 1;12(1):105-125. doi: 10.7150/thno.63788. eCollection 2022. Theranostics. 2022. PMID: 34987637 Free PMC article.

10

A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response.

Kim JY, Cho TM, Park JM, Park S, Park M, Nam KD, Ko D, Seo J, Kim S, Jung E, Farrand L, Nguyen CT, Hoang VH, Thanh La M, Ann J, Nam G, Park HJ, Lee J, Kim YJ, Seo JH. Kim JY, et al. Among authors: park s, park m, park jm, park hj. Oncogene. 2022 Jun;41(23):3289-3297. doi: 10.1038/s41388-022-02269-y. Epub 2022 May 2. Oncogene. 2022. PMID: 35501463 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,136 results

Search Page